PHASE-3 NORTH-AMERICAN TRIAL OF ROQUINIMEX (LINOMIDE) IN RELAPSING-REMITTING AND SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS (MS) - CLINICAL-RESULTS

Citation
Jh. Noseworthy et al., PHASE-3 NORTH-AMERICAN TRIAL OF ROQUINIMEX (LINOMIDE) IN RELAPSING-REMITTING AND SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS (MS) - CLINICAL-RESULTS, Neurology, 50(4), 1998, pp. 4003-4003
Citations number
NO
Categorie Soggetti
Clinical Neurology
Journal title
ISSN journal
00283878
Volume
50
Issue
4
Year of publication
1998
Supplement
4
Pages
4003 - 4003
Database
ISI
SICI code
0028-3878(1998)50:4<4003:PNTOR(>2.0.ZU;2-Q